<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: research consortium</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Discovery of gene involved in fatty liver disease</title>
   	 <description>An international research consortium led by CIC bioGUNE has discovered the involvement of a gene in the development of non-alcoholic fatty liver disease (NAFLD). Although the gene concerned (SLC2A1) had never previously been linked to liver disease, it appears to be involved in the development of this disorder. NAFLD is currently one of the leading causes of chronic liver disease in the world.</description>
     <link>http://medicalxpress.com/news/2013-04-discovery-gene-involved-fatty-liver.html</link>
	 <category>Genetics</category>
	 <pubDate>Wed, 24 Apr 2013 06:57:42 EST</pubDate>
	 <guid isPermaLink="false">news286005454</guid>
	 
</item>
<item>
     <title>Research advances therapy to protect against dengue virus</title>
   	 <description>Nearly half of the world's population is at risk of infection by the dengue virus, yet there is no specific treatment for the disease. Now a therapy to protect people from the virus could finally be a step closer, thanks to a team at MIT.</description>
     <link>http://medicalxpress.com/news/2013-04-advances-therapy-dengue-virus.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 08 Apr 2013 16:18:40 EST</pubDate>
	 <guid isPermaLink="false">news284656447</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/researchadva.jpg" width="90" height="90" />
</item>
<item>
     <title>DNA sequencing: Changing the landscape of science and biology</title>
   	 <description>UConn researchers are at the forefront of new discoveries and understanding about the smallest molecules in the body that can have a momentous impact on human health.</description>
     <link>http://medicalxpress.com/news/2013-03-dna-sequencing-landscape-science-biology.html</link>
	 <category>Genetics</category>
	 <pubDate>Tue, 26 Mar 2013 08:21:37 EST</pubDate>
	 <guid isPermaLink="false">news283504887</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/dnasequencin.jpg" width="90" height="90" />
</item>
<item>
     <title>EU releases 144 mn euro for new rare disease research</title>
   	 <description>The European Union on Thursday pledged 144 million euros of fresh funding for research on rare diseases that currently affect some 30 million Europeans, the majority of them children.</description>
     <link>http://medicalxpress.com/news/2013-02-eu-mn-euro-rare-disease.html</link>
	 <category>Genetics</category>
	 <pubDate>Thu, 28 Feb 2013 04:50:01 EST</pubDate>
	 <guid isPermaLink="false">news281247852</guid>
	 
</item>
<item>
     <title>Study suggests tightening up of criteria for definition of intrauterine growth restriction</title>
   	 <description>In a study to be presented on February 14 at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Francisco, researchers will report that the practice of using an arbitrary Estimated Fetal Weight (EFW) less than the 10th centile may not be an efficient practice for defining true Intrauterine Growth Restriction (IUGR).</description>
     <link>http://medicalxpress.com/news/2013-02-tightening-criteria-definition-intrauterine-growth.html</link>
	 <category>Obstetrics &amp; gynaecology</category>
	 <pubDate>Mon, 11 Feb 2013 10:09:37 EST</pubDate>
	 <guid isPermaLink="false">news279799766</guid>
	 
</item>
<item>
     <title>New drug improves survival in multiple myeloma relapse</title>
   	 <description>Researchers at Moffitt Cancer Center and colleagues have investigated the safety, efficacy and the maximum tolerated dose of pomalidomide for patients with multiple myeloma who have disease relapsed after treatments with other drugs, such as bortezomib and lenalidomide. This phase I clinical trial enrolled 38 patients, and pomalidomide provided a minimal or better response for 42 percent of the patients, a partial response or better for 21 percent, and a complete response for 3 percent.</description>
     <link>http://medicalxpress.com/news/2013-01-drug-survival-multiple-myeloma-relapse.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 24 Jan 2013 04:00:10 EST</pubDate>
	 <guid isPermaLink="false">news278222362</guid>
	 
</item>
<item>
     <title>'Bas-Congo': Genetic sleuthing uncovers deadly new virus in Africa</title>
   	 <description>An isolated outbreak of a deadly disease known as acute hemorrhagic fever, which killed two people and left one gravely ill in the Democratic Republic of Congo in the summer of 2009, was probably caused by a novel virus scientists have never seen before.</description>
     <link>http://medicalxpress.com/news/2012-09-bas-congo-genetic-sleuthing-uncovers-deadly.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 27 Sep 2012 17:02:03 EST</pubDate>
	 <guid isPermaLink="false">news267984105</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/geneticsleut.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists have way to control sugars that lead to diabetes, obesity</title>
   	 <description>(Medical Xpress)—Scientists can now turn on or off the enzymes responsible for processing starchy foods into sugars in the human digestive system, a finding they believe will allow them to better control those processes in people with type 2 diabetes and obesity.</description>
     <link>http://medicalxpress.com/news/2012-09-scientists-sugars-diabetes-obesity.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 26 Sep 2012 07:26:31 EST</pubDate>
	 <guid isPermaLink="false">news267863091</guid>
	 
</item>
<item>
     <title>Tavi study shows low mortality rate, improvement in function at 30 days</title>
   	 <description>Patients who underwent transcatheter aortic valve implantation (TAVI) at experienced medical centers had significant improvement in valve function as well as low mortality and stroke rates at 30 days, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session. The Scientific Session, the premier cardiovascular medical meeting, brings cardiovascular professionals together to further advances in the field.</description>
     <link>http://medicalxpress.com/news/2012-03-tavi-mortality-function-days.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 26 Mar 2012 09:09:13 EST</pubDate>
	 <guid isPermaLink="false">news251971746</guid>
	 
</item>
<item>
     <title>Quantitative CT helps identify COPD patitients at risk for exacerbations</title>
   	 <description>(Medical Xpress) -- National Jewish Health researchers and their colleagues in the COPDGene research consortium report that a computerized form of radiology, known as quantitative CT, can offer valuable prognostic information for patients and doctors beyond the standard breathing tests most commonly used to evaluate chronic obstructive pulmonary disease (COPD).</description>
     <link>http://medicalxpress.com/news/2012-01-quantitative-ct-copd-patitients-exacerbations.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 03 Jan 2012 08:30:01 EST</pubDate>
	 <guid isPermaLink="false">news244801026</guid>
	 
</item>
<item>
     <title>Ineffective group dynamics play a role in poor research reporting</title>
   	 <description>Ineffective group dynamics within research groups and research collaborations contribute to the unrealistic picture of the data generated in scientific research, according to Judith Rosmalen and Albertine Oldehinkel from the University of Groningen in The Netherlands. In an Essay published in this week's PLoS Medicine, these researchers say: &quot;We feel it is time for scientists to also critically evaluate their own role, and acknowledge that group dynamics within research groups and collaborations might contribute to the persistence of problematic scientific practices.&quot;</description>
     <link>http://medicalxpress.com/news/2011-12-ineffective-group-dynamics-role-poor.html</link>
	 <category>Other</category>
	 <pubDate>Tue, 13 Dec 2011 17:00:10 EST</pubDate>
	 <guid isPermaLink="false">news243016672</guid>
	 
</item>


</channel>
</rss>
